While the precise molecular interaction mechanisms between these two receptors remain to be fully elucidated, these findings provide novel insights into the pathogenesis of post-mTBI cognitive impairment and highlight the therapeutic potential of dual-targeting p75NTR and Trem2 signaling pathways. The gene discussed is TREM2; the disease is Cognitive impairment.